AGTC-501 Gene Therapy Offers Vision Gains for X-Linked RP

AGTC-501 (Applied Genetic Technologies Corporation), a novel gene therapy in development for the potential treatment of X-linked retinitis pigmentosa (RP), showed an acceptable safety profile and visual function improvements when administered in the study’s higher dose groups, according to Robert A. Sisk, MD, FACS, from the Cincinnati Eye Institute in Ohio.

2022 Best Tech Startups in Gainesville

The Tech Tribune selected the best tech startups in Gainesville, and the top three are UF Innovate | Accelerate at The Hub graduates: Feathr, Admiral, and MYOLYN. MYOLYN is also a UF startup. Well done!

New and Upcoming Developments in Glaucoma Treatment

Glaucoma specialist, Dr. Amy Mehta, discusses new and upcoming developments in glaucoma treatment, including an advance by UF startup and UF Innovate | Accelerate at Sid Martin Biotech company TearClear.

Clinicians May Now Be Able To Tell COVID-19 From Seasonal Flu With Fast Turnaround Thanks to UF Research

Led by Dr. Z. Hugh Fan, Ph.D., professor at the Herbert Wertheim College of Engineering’s Department of Mechanical and Aerospace Engineering, and Dr. John Lednicky, Research Professor at the College of Public Health and Health Professions’ Department of Environmental and Global Health, an interdisciplinary team at the University of Florida has developed a game-changing diagnostic test for SARS-CoV-2 that is fast, reliable, low-cost and capable of differentiating between COVID-19 and influenza.